PubMed ID:
25039930
Public Release Type:
Journal
Publication Year: 2015
Affiliation: Division of Gastroenterology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, MI, 48109-0362, USA.
DOI:
https://doi.org/10.1111/liv.12632
Authors:
Fontana RJ,
Chung RT,
Chung RT,
Durkalski V,
Lee WM,
Lee WM,
Attar N,
Blei A,
Brown R,
Crippin J,
Davern T,
Davern T,
Dillon C,
Durkalski VE,
Ellerbe C,
Fix O,
Fix O,
Fontana R,
Ganger D,
Ganger DR,
Goddard T,
Han S,
Han SH,
Harrison E,
Hassanein T,
Hay JE,
Hynan LS,
Hynan LS,
Lalani E,
Larson AM,
Liou I,
Liou I,
McCashland T,
McGuire B,
McGuire B,
Munoz S,
Murray M,
Murray N,
Ostapowicz GA,
Pezzia C,
Polson J,
Rangnekar A,
Reddy R,
Reddy RK,
Reisch JS,
Reuben A,
Reuben A,
Rossaro L,
Samuel G,
Sanders C,
Sanders C,
Satyanarayana R,
Schilsky M,
Schilsky M,
Schiødt FV,
Shaikh A,
Smith A,
Smith JP,
Stravitz R,
Stravitz T,
US Acute Liver Failure Study Group,
Webster JW,
Zaman A,
Zhao W
Studies:
Acute Liver Failure Study Group: Adult Acute Liver Failure Study
The long-term clinical outcomes in initial survivors with acute liver failure (ALF) are not well known. The aim of this study was to provide an overview of the 2-year clinical outcomes among initial survivors and liver transplant (LT) recipients that were alive 3 weeks after enrolment in the Acute Liver Failure Study Group (ALFSG).